Can You Take Mounjaro With Gallstones?

You've been told you have gallstones and you're considering Mounjaro: here's the real picture

The first thing worth setting aside is the idea that a gallstone history is a flat-out veto. For many people it is not, and plenty of prescribers are comfortable proceeding where the condition is stable, asymptomatic, and fully disclosed. What matters is the detail: are the stones currently causing symptoms? Have you had a gallbladder attack recently? Is your gallbladder still intact? These are the questions a prescriber will work through.

Gallbladder disease appears as a known adverse effect in the Mounjaro SmPC on the eMC, which covers everything from cholecystitis (inflamed gallbladder) to cholelithiasis (stone formation). The mechanism is partly explained by the effect of GLP-1 and GIP receptor activation on gallbladder motility, the gallbladder empties less often when gastric transit slows, and bile that sits longer can crystallise into new stones. If you already have stones present, that background risk is something your prescriber will factor in.

If you want to understand how Mounjaro relates to gallbladder health in more detail, that page goes through the physiology and the clinical picture clearly. The short version: existing stones do not make treatment impossible, but they do make a thorough conversation with a prescriber non-negotiable.

Rapid weight loss and gallstones, the part people often miss

There is a widespread assumption that gallstones on tirzepatide are purely a drug effect. The reality is more layered. Losing body weight quickly, by any route, raises the risk of new stone formation. Fat mobilisation shifts bile composition, and when weight comes off fast, cholesterol in bile can reach concentrations that encourage crystallisation. This happens with very-low-calorie diets, after bariatric surgery, and with effective weight-loss medicines.

In the SURMOUNT-1 trial, involving thousands of adults with obesity, gallbladder-related events occurred in a small proportion of participants but were more common than in the placebo group, a pattern seen across GLP-1 medicines generally. The NHS patient information page for tirzepatide lists gallbladder problems among the side effects to watch for, and advises contacting a doctor if symptoms develop.

This context matters because it reframes the question slightly. The risk is not just about the medicine sitting on top of existing stones; it is also about what successful treatment does to your body. Someone who loses 15–20% of their body weight over 18 months is in a different metabolic position by the end. Your prescriber will think about both directions of risk: the disease risk of remaining at a higher weight, and the procedural risk of accelerated loss. For more on how to avoid gallstones while taking Mounjaro, practical guidance is available separately, and you can also find advice on preventing gallstones on Mounjaro if you want to go into that topic in more depth.

When to get medical help, and what not to ignore

On any GLP-1 medicine, certain symptoms need same-day or emergency medical attention. Severe pain in your upper abdomen or right side, especially if it radiates toward your back or right shoulder, can indicate a gallbladder attack or, less commonly, pancreatitis. Neither should be waited out. The MHRA issued a Drug Safety Update in January 2026 specifically flagging acute pancreatitis as an infrequent but serious risk with GLP-1 medicines: sudden, intense stomach pain that persists and moves to the back is the key warning sign. Nausea and vomiting alongside that pain make it more urgent, not less.

If you are already aware that you have gallstones and you start Mounjaro, it is sensible to understand what taking Mounjaro with gallstones involves in practice, including how to note what your baseline abdominal discomfort feels like, as some people with stones have occasional mild niggles that are nothing new. A significant change in character, severity, or duration is worth reporting to your prescriber or the aftercare team rather than attributing it automatically to normal GI side effects of the medicine. You can also report any suspected side effects through the MHRA Yellow Card scheme, which helps regulators track emerging patterns across the population.

For people wondering about the cost side of treatment alongside these clinical considerations, what Mounjaro actually costs through a regulated private pharmacy is explained clearly on that page, worth reading before making any decisions.

What happens at the nume consultation if you have gallstones

At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber, a real clinician, on the same day you submit. If you have gallstones or a history of gallbladder disease, you will be asked about it. That is not a hurdle; it is the prescriber doing their job. The answer you give shapes what happens next: stable, asymptomatic stones in an otherwise suitable candidate is a different clinical picture from active, recurring biliary colic.

If treatment is appropriate for you, it is dispatched the same day for free next-working-day delivery. If there are clinical reasons to pause or explore further, the prescriber will tell you why. You can read more about tirzepatide and how it works or explore the weight-loss treatments nume offers to see what is available. When you are ready to talk through your own history, speak to our prescribers through a free consultation.